Dechra Pharmaceuticals (DCHPF) Short Interest Ratio & Short Volume $46.90 0.00 (0.00%) As of 01/18/2024 Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Dechra Pharmaceuticals Short Interest DataDechra Pharmaceuticals (DCHPF) has a short interest of 24,600 shares. This marks a -13.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1,687 shares to cover all short positions.Current Short Interest24,600 sharesPrevious Short Interest28,400 sharesChange Vs. Previous Month-13.38%Dollar Volume Sold Short$1.15 millionShort Interest Ratio0.0 Days to CoverLast Record DateJanuary 15, 2024Today's Trading Volume0 sharesAverage Trading Volume1,687 sharesToday's Volume Vs. Average0% Short Selling Dechra Pharmaceuticals? Sign up to receive the latest short interest report for Dechra Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDCHPF Short Interest Over TimeDCHPF Days to Cover Over TimeDCHPF Percentage of Float Shorted Over Time Dechra Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/202424,600 shares $1.15 million -13.4%N/A0 $46.90 12/31/202328,400 shares $1.33 million -3.4%N/A437 $46.90 12/15/202329,400 shares $1.38 million +3.5%N/A294 $46.90 11/30/202328,400 shares $1.33 million -6.0%N/A0 $46.90 11/15/202330,200 shares $1.42 million -1.0%N/A302 $47.00 10/31/202330,500 shares $1.43 million +3.0%N/A0 $47.00 10/15/202329,600 shares $1.39 million No ChangeN/A0 $47.00 9/30/202329,600 shares $1.39 million -61.9%N/A74 $47.00 9/15/202377,600 shares $3.67 million +32.0%N/A86.2 $47.32 8/31/202358,800 shares $2.73 million +17.6%N/A0 $46.50 Get the Latest News and Ratings for DCHPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dechra Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/15/202350,000 shares $2.33 million -39.4%N/A0 $46.50 7/31/202382,500 shares $3.84 million -55.8%N/A0 $46.50 7/15/2023186,500 shares $8.67 million -40.4%N/A932.5 $46.50 6/30/2023312,900 shares $14.16 million +50.0%N/A0 $45.25 6/15/2023208,600 shares $9.44 million -2.3%N/A149 $45.25 5/31/2023213,500 shares $6.41 million -49.0%N/A0 $30.00 5/15/2023418,200 shares $12.55 million +24.0%N/A0 $30.00 4/30/2023337,400 shares $10.12 million +123.2%N/A3374 $30.00 4/15/2023151,200 shares $4.54 million -3.9%N/A1512 $30.00 3/31/2023157,400 shares $4.93 million No ChangeN/A1574 $31.35 3/15/2023157,400 shares $4.93 million -3.0%N/A787 $31.35 2/28/2023162,300 shares $6.02 million +2.9%N/A1623 $37.10 2/15/2023157,700 shares $5.81 million -52.4%N/A788.5 $36.84 1/31/2023331,100 shares $10.76 million +93.6%N/A1103.7 $32.50 1/15/2023171,000 shares $5.54 million -53.9%N/A1710 $32.40 12/30/2022370,900 shares $11.96 million +120.1%N/A1236.3 $32.25 12/15/2022168,500 shares $5.65 million -51.9%N/A1685 $33.55 11/30/2022350,600 shares $11.78 million +104.4%N/A0 $33.60 11/15/2022171,500 shares $5.76 million -4.6%N/A428.8 $33.60 10/31/2022179,800 shares $5.02 million +6.5%N/A1798 $27.90 10/15/2022168,900 shares $4.71 million -2.2%N/A1689 $27.90 9/30/2022172,700 shares $7.38 million +1.8%N/A1727 $42.75 9/15/2022169,600 shares $7.25 million -0.4%N/A1696 $42.75 8/31/2022170,300 shares $7.28 million +2.7%N/A340.6 $42.75 8/15/2022165,900 shares $7.09 million -0.8%N/A0 $42.75 7/31/2022167,200 shares $7.15 million -13.7%N/A1672 $42.75 7/15/2022193,700 shares $8.28 million +14.4%N/A1937 $42.75 6/30/2022169,300 shares $6.60 million +33.7%N/A0 $39.00 6/15/2022126,600 shares $4.94 million -9.2%N/A0 $39.00 5/31/2022139,400 shares $5.44 million +1.0%N/A0 $39.00URGENT: Someone's Moving Gold Out of London... (Ad)People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. Go here to learn about my Top Four picks for the coming bull mania. 5/15/2022138,000 shares $5.38 million No ChangeN/A690 $39.00 4/30/2022138,000 shares $7.56 million -3.0%N/A0 $54.80 4/15/2022142,200 shares $7.79 million -48.2%N/A1422 $54.80 3/31/2022274,500 shares $15.04 million +71.1%N/A0 $54.80 3/15/2022160,400 shares $8.79 million -22.3%N/A100.3 $54.80 2/28/2022206,300 shares $11.03 million -0.1%N/A2063 $53.45 2/15/2022206,400 shares $11.03 million +1.4%N/A0 $53.45 1/31/2022203,600 shares $10.88 million No ChangeN/A1018 $53.45 1/15/2022203,600 shares $13.74 million -37.6%N/A2036 $67.50 12/31/2021326,200 shares $22.02 million +46.5%N/A1631 $67.50 12/15/2021222,600 shares $14.61 million -32.2%N/A742 $65.65 11/30/2021328,300 shares $21.64 million +48.8%N/A3283 $65.90 11/15/2021220,600 shares $14.54 million +29.9%N/A1103 $65.90 10/29/2021169,800 shares $12.06 million +6.9%N/A1698 $71.00 10/15/2021158,800 shares $10.49 million -18.3%N/A1588 $66.07 9/30/2021194,300 shares $13.22 million +82.6%N/A0 $68.05 9/15/2021106,400 shares $7.24 million -41.8%N/A266 $68.05 8/31/2021182,800 shares $13.07 million +73.6%N/A304.7 $71.50 8/13/2021105,300 shares $7.50 million +0.2%N/A1053 $71.25 7/30/2021105,100 shares $7.20 million No ChangeN/A350.3 $68.50 7/15/2021105,100 shares $6.92 million -47.6%N/A1051 $65.80 6/30/2021200,400 shares $12.19 million +89.4%N/A501 $60.84 6/15/2021105,800 shares $5.80 million No ChangeN/A1058 $54.80 5/28/2021105,800 shares $5.80 million No ChangeN/A0 $54.80 5/14/2021105,800 shares $5.80 million -55.0%N/A1058 $54.80 4/30/2021234,900 shares $11.94 million +128.5%N/A0 $50.85 4/15/2021102,800 shares $5.23 million -0.1%N/A1028 $50.85 3/31/2021102,900 shares $5.00 million -0.4%N/A257.3 $48.63 3/15/2021103,300 shares $4.80 million +4.3%N/A1033 $46.50 2/26/202199,000 shares $4.81 million No ChangeN/A0 $48.63 2/12/202199,000 shares $4.50 million No ChangeN/A990 $45.50 1/29/202199,000 shares $4.50 million -1.6%N/A0 $45.50 1/15/2021100,600 shares $4.58 million No ChangeN/A1006 $45.50 12/31/2020262,500 shares $11.94 million +160.9%N/A2625 $45.50 12/15/2020100,600 shares $4.58 million No ChangeN/A1006 $45.50 11/30/2020100,600 shares $4.58 million -0.2%N/A1006 $45.50 11/15/2020100,800 shares $4.59 million +0.1%N/A1008 $45.50 10/30/2020100,700 shares $4.52 million -0.7%N/A1007 $44.90 10/15/2020101,400 shares $4.42 million +1.2%N/A1014 $43.60 9/30/2020100,200 shares $4.37 million No ChangeN/A1002 $43.60 9/15/2020100,200 shares $4.05 million -1.9%N/A0 $40.44 8/31/2020102,100 shares $4.17 million -0.8%N/A340.3 $40.85 8/14/2020102,900 shares $4.27 million -74.9%N/A1029 $41.50 7/31/2020409,700 shares $14.03 million +281.8%N/A4097 $34.24 7/15/2020107,300 shares $3.67 million -4.9%N/A0 $34.24 6/30/2020112,800 shares $3.86 million +0.5%N/A1128 $34.24 6/15/2020112,200 shares $3.84 million -74.4%N/A0 $34.24 5/29/2020438,300 shares $15.01 million +270.8%N/A0 $34.24 5/15/2020118,200 shares $3.88 million -0.6%N/A90.9 $32.83 DCHPF Short Interest - Frequently Asked Questions What is Dechra Pharmaceuticals' current short interest? Short interest is the volume of Dechra Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 15th, investors have sold 24,600 shares of DCHPF short. Learn More on Dechra Pharmaceuticals' current short interest. Is Dechra Pharmaceuticals' short interest increasing or decreasing? Dechra Pharmaceuticals saw a drop in short interest in January. As of January 15th, there was short interest totaling 24,600 shares, a drop of 13.4% from the previous total of 28,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Dechra Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "personal services" compare to Dechra Pharmaceuticals: Roche Holding AG (0.07%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Dechra Pharmaceuticals stock? Short selling DCHPF is an investing strategy that aims to generate trading profit from Dechra Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dechra Pharmaceuticals? A short squeeze for Dechra Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DCHPF, which in turn drives the price of the stock up even further. How often is Dechra Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DCHPF, twice per month. The most recent reporting period available is January, 15 2024. More Short Interest Resources from MarketBeat Related Companies Aalberts Short Interest Data Absa Group Short Interest Data Air China Short Interest Data Airbus Short Interest Data Airports of Thailand Public Short Interest Data Akbank T.A.S. Short Interest Data Amada Short Interest Data Anadolu Efes Biracilik ve Malt Sanayii Anonim Sirketi Short Interest Data Asia Broadband Short Interest Data ATEX Resources Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:DCHPF) was last updated on 5/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dechra Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Dechra Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.